A citation-based method for searching scientific literature

Khaldoun Almhanna, Maria Luisa Limon Miron, David Wright, Antonio Cubillo Gracian, Richard A Hubner, Jean-Luc Van Laethem, Carolina Muriel López, Maria Alsina, Frederico Longo Muñoz, Johanna Bendell, Irfan Firdaus, Wells Messersmith, Zhan Ye, Adedigbo A Fasanmade, Hadi Danaee, Thea Kalebic. Invest New Drugs 2017
Times Cited: 13







List of co-cited articles
150 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
Hadi Danaee, Thea Kalebic, Timothy Wyant, Matteo Fassan, Claudia Mescoli, Feng Gao, William L Trepicchio, Massimo Rugge. PLoS One 2017
24
46

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
Khaldoun Almhanna, David Wright, Teresa Macarulla Mercade, Jean-Luc Van Laethem, Antonio Cubillo Gracian, Carmen Guillen-Ponce, Jason Faris, Carolina Muriel Lopez, Richard A Hubner, Johanna Bendell,[...]. Invest New Drugs 2017
18
46

Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies.
Khaldoun Almhanna, Thea Kalebic, Cristina Cruz, Jason E Faris, David P Ryan, JungAh Jung, Tim Wyant, Adedigbo A Fasanmade, Wells Messersmith, Jordi Rodon. Clin Cancer Res 2016
25
38

Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer.
Colin D Weekes, Laetitia E Lamberts, Mitesh J Borad, Johannes Voortman, Robert R McWilliams, Jennifer R Diamond, Elisabeth G E de Vries, Henk M Verheul, Christopher H Lieu, George P Kim,[...]. Mol Cancer Ther 2016
68
30

Fate of Antibody-Drug Conjugates in Cancer Cells.
Cécile Chalouni, Sophia Doll. J Exp Clin Cancer Res 2018
84
30

Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Ruth Birbe, Juan P Palazzo, Rhonda Walters, David Weinberg, Stephanie Schulz, Scott A Waldman. Hum Pathol 2005
97
30

A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
Melissa Gallery, Julie Zhang, Daniel P Bradley, Pamela Brauer, Donna Cvet, Jose Estevam, Hadi Danaee, Edward Greenfield, Ping Li, Mark Manfredi,[...]. PLoS One 2018
16
30

Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
S L Carrithers, M T Barber, S Biswas, S J Parkinson, P K Park, S D Goldstein, S A Waldman. Proc Natl Acad Sci U S A 1996
182
30

Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications.
Nirnoy Dan, Saini Setua, Vivek K Kashyap, Sheema Khan, Meena Jaggi, Murali M Yallapu, Subhash C Chauhan. Pharmaceuticals (Basel) 2018
108
23

Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates.
Muhammad Kalim, Jie Chen, Shenghao Wang, Caiyao Lin, Saif Ullah, Keying Liang, Qian Ding, Shuqing Chen, Jinbiao Zhan. Drug Des Devel Ther 2017
52
23


Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach.
Jason Park, Stephanie Schulz, Janis Haaf, John C Kairys, Scott A Waldman. Cancer Epidemiol Biomarkers Prev 2002
29
23

Antibody-drug conjugate directed against the guanylyl cyclase antigen for the treatment of gastrointestinal malignancies.
Khaldoun Almhanna, Gopi K Prithviraj, Petter Veiby, Thea Kalebic. Pharmacol Ther 2017
11
27

Mechanisms of Resistance to Antibody-Drug Conjugates.
Frank Loganzo, Matthew Sung, Hans-Peter Gerber. Mol Cancer Ther 2016
81
23

Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
Hao Chen, Zongtao Lin, Kinsie E Arnst, Duane D Miller, Wei Li. Molecules 2017
94
23

Antibody-drug conjugates--an emerging class of cancer treatment.
Nikolaos Diamantis, Udai Banerji. Br J Cancer 2016
280
23


First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors.
Geoffrey I Shapiro, Ulka N Vaishampayan, Patricia LoRusso, Jeremy Barton, Steven Hua, Steven D Reich, Ronald Shazer, Carrie T Taylor, Dawei Xuan, Hossein Borghaei. Invest New Drugs 2017
26
23

Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study.
Toshihiko Doi, Kohei Shitara, Yoichi Naito, Akihiko Shimomura, Yasuhiro Fujiwara, Kan Yonemori, Chikako Shimizu, Tatsunori Shimoi, Yasutoshi Kuboki, Nobuaki Matsubara,[...]. Lancet Oncol 2017
201
23

Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer.
Efrat Dotan, Steven J Cohen, Alexander N Starodub, Christopher H Lieu, Wells A Messersmith, Pamela S Simpson, Michael J Guarino, John L Marshall, Richard M Goldberg, J Randolph Hecht,[...]. J Clin Oncol 2017
47
23

Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index.
Steven Coats, Marna Williams, Benjamin Kebble, Rakesh Dixit, Leo Tseng, Nai-Shun Yao, David A Tice, Jean-Charles Soria. Clin Cancer Res 2019
148
23

Acquired Resistance to Antibody-Drug Conjugates.
Denis M Collins, Birgit Bossenmaier, Gwendlyn Kollmorgen, Gerhard Niederfellner. Cancers (Basel) 2019
56
23

Calorie-induced ER stress suppresses uroguanylin satiety signaling in diet-induced obesity.
G W Kim, J E Lin, A E Snook, A S Aing, D J Merlino, P Li, S A Waldman. Nutr Diabetes 2016
27
23


Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
23

Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Daniel J Sargent, Murray B Resnick, Michael O Meyers, Atoussa Goldar-Najafi, Thomas Clancy, Sharlene Gill, Gary O Siemons, Qian Shi, Brian M Bot, Tsung-Teh Wu,[...]. Ann Surg Oncol 2011
23
23

Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity.
Amanda M Pattison, Joshua R Barton, Ariana A Entezari, Alicja Zalewski, Jeff A Rappaport, Adam E Snook, Scott A Waldman. Cancer Biol Ther 2020
8
37

GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer.
Glen P Marszalowicz, Adam E Snook, Michael S Magee, Dante Merlino, Lisa D Berman-Booty, Scott A Waldman. Oncotarget 2014
20
23

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
Michael A Valentino, Jieru E Lin, Adam E Snook, Peng Li, Gilbert W Kim, Glen Marszalowicz, Michael S Magee, Terry Hyslop, Stephanie Schulz, Scott A Waldman. J Clin Invest 2011
109
23

Colorectal cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer, Stacey A Fedewa, Lynn F Butterly, Joseph C Anderson, Andrea Cercek, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2020
23

Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
Adam E Snook, Benjamin J Stafford, Peng Li, Gene Tan, Lan Huang, Ruth Birbe, Stephanie Schulz, Matthias J Schnell, Mathew Thakur, Jay L Rothstein,[...]. J Natl Cancer Inst 2008
41
23

The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
88
23

Expression of guanylin is downregulated in mouse and human intestinal adenomas.
K A Steinbrecher, T M Tuohy, K Heppner Goss, M C Scott, D P Witte, J Groden, M B Cohen. Biochem Biophys Res Commun 2000
70
23

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity.
Michael S Magee, Crystal L Kraft, Tara S Abraham, Trevor R Baybutt, Glen P Marszalowicz, Peng Li, Scott A Waldman, Adam E Snook. Oncoimmunology 2016
45
23

Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases.
Michael S Magee, Tara S Abraham, Trevor R Baybutt, John C Flickinger, Natalie A Ridge, Glen P Marszalowicz, Priyanka Prajapati, Adam R Hersperger, Scott A Waldman, Adam E Snook. Cancer Immunol Res 2018
66
23

Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
K Shailubhai, H H Yu, K Karunanandaa, J Y Wang, S L Eber, Y Wang, N S Joo, H D Kim, B W Miedema, S Z Abbas,[...]. Cancer Res 2000
173
23

Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine.
Peng Li, Jieru E Lin, Inna Chervoneva, Stephanie Schulz, Scott A Waldman, Giovanni M Pitari. Am J Pathol 2007
93
23

APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
Erik S Blomain, Jeffrey A Rappaport, Amanda M Pattison, Babar Bashir, Ellen Caparosa, Jonathan Stem, Adam E Snook, Scott A Waldman. Cancer Biol Ther 2020
7
42

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
John C Flickinger, Jagmohan Singh, Robert Carlson, Elinor Leong, Trevor R Baybutt, Joshua Barton, Ellen Caparosa, Amanda Pattison, Jeffrey A Rappaport, Jamin Roh,[...]. J Immunother Cancer 2020
12
25


Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
107
23

Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.
Bo Xiang, Trevor R Baybutt, Lisa Berman-Booty, Michael S Magee, Scott A Waldman, Vitali Y Alexeev, Adam E Snook. J Immunol 2017
24
23

The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Chantell Wilson, Jieru E Lin, Peng Li, Adam E Snook, Jianping Gong, Takahiro Sato, Chengbao Liu, Melanie A Girondo, Hallgeir Rui, Terry Hyslop,[...]. Cancer Epidemiol Biomarkers Prev 2014
40
23

Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
Jieru E Lin, Francheska Colon-Gonzalez, Erik Blomain, Gilbert W Kim, Amanda Aing, Brian Stoecker, Justin Rock, Adam E Snook, Tingting Zhan, Terry M Hyslop,[...]. Cancer Res 2016
41
23

Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.
Adam E Snook, Trevor R Baybutt, Bo Xiang, Tara S Abraham, John C Flickinger, Terry Hyslop, Tingting Zhan, Walter K Kraft, Takami Sato, Scott A Waldman. J Immunother Cancer 2019
29
23

Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.
Adam E Snook, Michael S Magee, Stephanie Schulz, Scott A Waldman. Eur J Immunol 2014
32
23

Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Martin Beaulieu, Marie Desaulniers, Nicolas Bertrand, Réna G Deschesnes, Guillaume Beaudry, Geneviève Garon, Jean-François Haince, Michel Houde, Timothy J Holzer. Diagn Mol Pathol 2010
20
23

Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.
Jean-François Haince, Michel Houde, Guillaume Beaudry, Sylvain L'espérance, Geneviève Garon, Marie Desaulniers, Laurie J Hafer, James I Heald, Stephen Lyle, Steven R Grossman,[...]. J Clin Pathol 2010
29
23

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
98
23

Antibody-Drug Conjugates: Possibilities and Challenges.
Mohammad-Reza Nejadmoghaddam, Arash Minai-Tehrani, Ramin Ghahremanzadeh, Morteza Mahmoudi, Rassoul Dinarvand, Amir-Hassan Zarnani. Avicenna J Med Biotechnol 2019
78
23


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.